SCHEMBL24601589

SCHEMBL24601589

c1ccc(-c2cccc3c2c2c4c5ccccc5n5c6cccc(-c7ccccc7)c6c(c6c7ccccc7n3c62)c45)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.36
HTR6 P50406 2/20 0.36
LIMK1 P53667 3/20 0.34
CLK4 Q9HAZ1 2/20 0.34
PLK4 O00444 1/20 0.34
MAPK9 P45984 1/20 0.34
AKT3 Q9Y243 1/20 0.34
MAPK14 Q16539 1/20 0.34
MAP4K4 O95819 1/20 0.33
CSF1R P07333 1/20 0.33
FGFR1 P11362 1/20 0.33
PDGFRA P16234 1/20 0.33
LTK P29376 1/20 0.33
KDR P35968 1/20 0.33
MAPK8 P45983 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CDK5 Q00535 1/20 0.33
ACVR1 Q04771 1/20 0.33
TNK2 Q07912 1/20 0.33
AURKB Q96GD4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601531 0.91 LIMK1 (0.39) HSD17B10HTR6LIMK1CLK4PLK4
SCHEMBL24601602 0.84 NR1H4 (0.36) RETKDM4EMAPTMEN1KMT2A
SCHEMBL24601541 0.84 NR1H4 (0.36) RETKDM4EMAPTMEN1KMT2A
SCHEMBL24601430 0.81 HSD17B10 (0.36) HSD17B10HTR6LIMK1CLK4MAPK14
SCHEMBL24601649 0.81 HSD17B10 (0.36) HSD17B10HTR6LIMK1CLK4MAPK14
SCHEMBL21718027 0.81 KDM4E (0.38) HSD17B10HTR6LIMK1CLK4PLK4
SCHEMBL24601445 0.80 HSD17B10 (0.34) HSD17B10HTR6LIMK1CLK4MAPK14
SCHEMBL22178583 0.80 HSD17B10 (0.37) HSD17B10HTR6RETKDM4EMAPT
SCHEMBL22178594 0.80 HSD17B10 (0.37) HSD17B10HTR6LIMK1MAPK14RET
SCHEMBL24601624 0.80 HSD17B10 (0.35) HSD17B10HTR6MAPK14RETKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 HSD17B10 4661/4885HTR6 3265/4885LIMK1 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.